Search

Your search keyword '"Zwaan CM"' showing total 345 results

Search Constraints

Start Over You searched for: Author "Zwaan CM" Remove constraint Author: "Zwaan CM"
345 results on '"Zwaan CM"'

Search Results

2. Pharmacokinetics of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia or acute lymphoblastic leukemia

8. The genetic basis and cell of origin of mixed phenotype acute leukaemia.

9. Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study

10. t(6;9)(p22; q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients

11. Acute lymphoblastic leukemia in children with Down syndrome: A retrospective analysis from the Ponte di Legno study group

13. Identification of novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia

14. The MLL recombinome of acute leukemias in 2013

17. Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study.

18. Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference

19. The role of the Innovative Therapies for Children with Cancer' (ITCC) European consortium

20. Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study

21. t(3;11)(q13.13;q23) MLL/KIAA1524

24. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.

27. Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique.

28. t(6;9)(p22;q34)/DEK-NUP214 rearranged pediatric myeloid leukemia: an international study on 62 patients

29. Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community.

30. Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22 + acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial.

31. NUP98 oncofusions in myeloid malignancies: An update on molecular mechanisms and therapeutic opportunities.

32. Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART.

33. A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.

34. Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).

35. Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial.

36. Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials.

37. Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer.

38. Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms.

39. Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience.

41. Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059.

42. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

43. Targeting the innate immune system in pediatric and adult AML.

44. Naked antibodies and antibody-drug conjugates: targeted therapy for childhood acute lymphoblastic leukemia.

45. Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A -Rearranged Acute Lymphoblastic and Myeloid Leukemia.

46. Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA-JMML-001 trial.

47. A 14-year-old girl with premature ovarian insufficiency but with a positive pregnancy test.

48. Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.

49. Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

50. Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors.

Catalog

Books, media, physical & digital resources